Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
Ali-Jackson Kamil received 5,750 Rigel Pharmaceuticals, Inc. shares as an award (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Ali-Jackson Kamil (Director) received 5,750 Rigel Pharmaceuticals, Inc. shares as an award, leaving 15,125 shares. Filed May 19, 2026 (Form 4).
- Awarded
- 5,750 shares
- Holding after
- 15,125 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Award | 5,750 | 15,125 | Direct |
Source
Related
- Rigel Pharmaceuticals, Inc.
- Ali-Jackson Kamil
- Rigel Pharmaceuticals, Inc. shareholders
- Form 4 · Ali-Jackson Kamil · Jun 24, 2026
- Form 4 · Ali-Jackson Kamil · May 28, 2026
- Form 4 · Schorno Dean L · Sep 3, 2026
- Form 4 · Santos David A · Sep 3, 2026
- Form 4 · Rodriguez Raul R · Sep 3, 2026
- Form 4 · Furey Raymond J. · Sep 3, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026